Abstract:ID 87555 Poster Board 494 Bioactive compounds sometimes possess unfavorable properties for drug development due to on-target, off-tissue mediated side effects or poor pharmacological properties. Activation of drug targets expressed in tissues not involved in therapeutic responses can limit medical application. One solution is to use analogue(s) or fragments of bioactive drugs that become activated only at sites of interest. Herein we describe the development of fragments of a peptidic GPCR ligand that can react to form a bioactive product upon exposure to a dimerizing agent that stimulates in situ assembly. To enhance specificity, we developed methods for the directed delivery of such a dimerizing agent to cell types of choice. We sought to apply this approach for activation of the parathyroid hormone receptor-1 (PTHR1), which regulates skeletal development and mineral ion homeostasis. The prototypical peptide agonist of PTHR1 (PTH 1-34 ) was separated into two constituent fragments (PTH 1-11 and PTH 12-34 ), each of which possesses little to no biological activity alone. In situ synthesis of conjugates that resemble PTH 1-34 was achieved through peptide template-induced dimerization and click (azide-alkyne) reactions between the fragment peptides PTH 1-11 and PTH 12-34. Dimerization is facilitated through the binding of nanobodies (Nbs) to peptide tags as described below. Nbs are single antigen recognition domains of heavy-chain only antibodies, which exhibit specificity and affinity for biological macromolecules comparable to conventional antibodies. Templated dimerization was achieved by fusing PTH fragments containing click chemistry handles to one of two Nbs that bind to short peptide epitopes. A heterodimeric peptide (HDP), comprised of the two distinct Nb-binding peptide epitopes, was used to bring fusions comprised of Nbs and PTH fragments with complementary click handles, into proximity. HDP-induced co-localization was designed to trigger the click reaction within the cellular medium at high dilution. Gel electrophoresis analysis of the kinetics of the reaction between azide- and alkyne-functionalized Nbs showed that HDP-mediated dimerization accelerated reaction kinetics. In the context of a cell-based assays, PTH fragment-click handle-Nb conjugates were weakly active alone or when added in tandem. The addition of HDP to the tandem mixture resulted in strong activation (via in situ ligand assembly) of PTHR1. We further demonstrate that dimeric peptide-induced in situ assembly can be achieved with cell-type specificity and high efficiency via Nb-based delivery of dimerizing agent. Altogether, this approach entails a new strategy for in situ synthesis of a bioactive agonist from its inactive fragment peptides. These results offer a path towards in situ assembly of bioactive molecules based on targeted delivery of dimerizing agents. These findings, coupled with the modular and programmable nature of our strategy, suggest the possibility of engineering similar approaches for the targeted synthesis of a diverse range of clinically relevant molecules in various in vitro and in vivo settings. This research was supported by the Intramural Research Program of the NIH, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Photocontrolled Reversible Amyloid Fibril Formation of Parathyroid Hormone-Derived Peptides

A Photo‐Switchable Peptide Fibril Esterase

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

Near-infrared Irradiation Controlled Thermo-Switchable Polymeric Photosensitizer against β-Amyloid Fibrillation

Photocontrol of the β-Hairpin Polypeptide Structure through an Optimized Azobenzene-Based Amino Acid Analogue

Structure and Dynamics of the Active Human Parathyroid Hormone Receptor-1.

Visible Light-Controlled Intracellular Synthesis of Supramolecular Peptide Nanostructures

Chemistry As an Expanding Resource in Protein Science: Fully Synthetic and Fully Active Human Parathyroid Hormone‐Related Protein (1–141)

Activation of PTH1 receptor using chimeric peptide templated in situ click reaction of nanobody conjugates

Controlled Fiberization of Dipeptide in Merging Phases Leads to Collagen Level Strength and Opto/electric Mechanofunctionalities

Photocleavable cyclic peptide for modifying protein − peptide interaction

Spiropyran‐Based Photoisomerizable α‐Amino Acid for Membrane‐Active Peptide Modification

Photo-crosslinking induced geometric restriction controls the self-assembly of diphenylalanine based peptides

Supramolecular Peptide Constructed by Molecular Lego Allowing Programmable Self-Assembly for Photodynamic Therapy

Polymorphic amyloid nanostructures of hormone peptides involved in glucose homeostasis display reversible amyloid formation

Amyloid transformations of phenol soluble modulin α1 in Staphylococcus aureus and their modulation deploying a prenylated chalcone

Chemical strategies to modify amyloidogenic peptides using iridium(iii) complexes: coordination and photo-induced oxidation

Induced and Inversed Circularly Polarized Luminescence of Achiral Thioflavin T Assembled on Peptide Fibril.

Optical Control of Protein Functions Via Genetically Encoded Photocaged Aspartic Acids.

Early events during the aggregation of Aβ 16-22 -derived switch-peptides tracked using protein charge transfer spectra